A Study of PTS for Patients With Solid Tumors

Withdrawn before enrolling · Phase 1

Conditions studied: Solid Tumor

In brief

The primary objective of this study is to determine the MTD of PTS following local and intratumoral injections over a treatment course of two 5-day cycles to patients with palpable advanced solid malignancies who have failed standard treatment.

Key facts

Study ID

NCT03448211

Run by

PTS International Inc.

People needed

0

Starts

2018-05-01

Expected to finish

2019-08-01

Last updated by the study team

2018-04-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects are diagnosed as unsuitable for surgical operations or refuse to do so.
• Subject's performance status is classified as Grade 0 to Grade 3. Estimated survival time should be longer than 6 months of time.
• Physical examinations show no serious functional disorders of the heart, liver, kidneys, or blood.
• Subjects were treated with radio or chemotherapy previously. A minimum of 2 to 3 months recovery time is required before treating with this investigational drug.
• Subject is diagnosed as intratracheal lesions with metastasized pulmonary cancer not suitable for surgery, or refuses to be operated.
• Subject should show lobular atelectasis with either complete or incomplete obstruction of the bronchi.
• Physical examinations should show no functional disorders of the heart, liver, kidneys, central nervous system, and blood.
• Subject performance status to be classified from Grade 0 to Grade 3, who can tolerate the fiberoptic bronchoscopy treatments.
• In-patient is preferred. When subject is in satisfactory conditions, the out Cpatient can also be enrolled in this trial.
• Two to three months recovery time is required for the subject has just received radio or chemotherapy.
• Emergency request, subjects with serious lobular atelectasis and almost complete obstruction of the bronchi.
• With the aid of a tracheal intubation and the help of the respirator, PTS may be intraumorally injected into the obstructed lesion via fiberoptic bronchoscopy outside of the tube, alongside of the intubation.

You may not qualify if…

• Pregnant women and children will not be used as test subjects.
• Subjects with serious functional disorders of the heart, liver, kidneys, or blood will be excluded.
• Subjects who do not want to participate in the trial will not be used as test subjects.
• Subject does not agree to participate.
• Subject performance status is Grade 4, and the one who does not want to tolerate the discomfort of the PTS treatments via fiberoptic bronchscopy.

Where it is running

• University of Pittsburgh — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.